Investigation of in-vitro Efficacy of Antibiotic Combinations and Presence of Carbapenemases in Multidrug-Resistant Klebsiella pneumoniae Isolates

dc.contributor.authorAksoy, Pelin Kamuran Duran
dc.contributor.authorCaliskan, Emel
dc.date.accessioned2026-07-01T11:39:14Z
dc.date.available2026-07-01T11:39:14Z
dc.date.issued2026
dc.departmentDüzce Üniversitesi
dc.description.abstractBackground: Multidrug resistance (MDR) is increasingly being detected in Klebsiella pneumoniae strains. The combined use of antibiotics is one of the important choices in the treatment of these infections. Objectives: This study aimed to evaluate the in vitro activity of the binary combinations of colistin (COL), meropenem (MEM), and ceftazidime/avibactam (CZA) against multidrug-resistant K pneumoniae clinical isolates and to identify carbapenemase genes. Methods: Between January 2022 and November 2023, randomly selected MDR K. pneumoniae isolates (n = 90) isolated from patient samples were included in the study. All isolates were investigated for carbapenem resistance genes using the PCR method. Additionally, the carbapenem inactivation method (CIM) was used as a phenotypic method to investigate carbapenemase production. Antimicrobial interactions (synergy test) were determined using the checkerboard method. Results: The most common carbapenem resistance gene was OXA-48 (72 isolates). The KPC gene was detected in 10 isolates, and the NDM gene in 5 isolates. A synergy test was performed on isolates randomly selected from among those resistant to at least one of the antibiotics COL, CZA, and MEM. Synergistic effect was detected in 50% of the COL-CZA combination, 75% of the MEM-CZA combination, and 45% of the MEM-COL combination. Conclusions: OXA-48 was the most frequently detected carbapenemase gene in MDR K pneumoniae isolates in our region, and KPC and NDM carbapenemase genes were also detected. The high synergy-partial synergy ratios identified in antibiotics may represent a promising treatment option for infections caused by MDR K pneumoniae, but this requires confirmation in studies with larger sample sizes.
dc.identifier.doi10.5812/jjm-169256
dc.identifier.issn2008-3645
dc.identifier.issn2008-4161
dc.identifier.issue2
dc.identifier.orcid0000-0002-7838-2067
dc.identifier.urihttps://doi.org/10.5812/jjm-169256
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23173
dc.identifier.volume19
dc.identifier.wosWOS:001700798700001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherBrieflands
dc.relation.ispartofJundishapur Journal of Microbiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260623
dc.subject[Keyword Not Available]
dc.titleInvestigation of in-vitro Efficacy of Antibiotic Combinations and Presence of Carbapenemases in Multidrug-Resistant Klebsiella pneumoniae Isolates
dc.typeArticle

Dosyalar